ESHRE. Continuation rates for oral contraceptives and hormone replacement therapy

By  

Human Reproduction, Vol. 15, Iss. 8, 2000-08 ,pp. : 1865-1871

Oxford University Press

Access to resources Recommend Favorite

Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy

By Gadducci Angiolo   Biglia Nicoletta   Cosio Stefania   Sismondi Piero   Riccardo Genazzani Andrea  

Gynecological Endocrinology, Vol. 26, Iss. 8, 2010-08 ,pp. : 568-577

Informa Healthcare

Access to resources Recommend Favorite

The changed ultrastructure of fibrin networks during use of oral contraception and hormone replacement

By Pretorius Etheresia   Oberholzer Hester   Spuy Wendy   Meiring Johannes  

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 4, 2010-11 ,pp. : 502-506

Springer Publishing Company

Access to resources Recommend Favorite

Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature

By Gadducci Angiolo   Barsotti Cecilia   Cosio Stefania   Domenici Lavinia   Riccardo Genazzani Andrea  

Gynecological Endocrinology, Vol. 27, Iss. 8, 2011-08 ,pp. : 597-604

Informa Healthcare

Access to resources Recommend Favorite

Influence of menopausal status and use of hormone replacement therapy on radiation dose from mammography in routine breast screening

By Whitaker C J   Kelly C M   Faulkner K   Stamp E C  

British Journal of Radiology, Vol. 79, Iss. 943, 2006-07 ,pp. : 597-602

British Institute of Radiology

Access to resources Recommend Favorite